Clinical Trials
4 trialsNCT02311959 2026-04-14
MAPAM-01
Institut Claudius Regaud
Phase 3 Completed
NCT06056843 2026-04-03
PUD
International Agency for Research on Cancer
Phase NA Completed
NCT03258593 2026-03-17
Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT02858310 2026-03-09
E7 TCR T Cells for Human Papillomavirus-Associated Cancers
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed